1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
R01 Research Project Grant (Parent R01 Clinical Trial Not Allowed) is sponsored by National Eye Institute (NEI), National Institutes of Health (NIH). The NIH R01 grant supports health-related research and is the original and historically oldest grant mechanism used by NIH.
This mechanism supports a discrete, specified, circumscribed project, established in its own right, to be carried out by the named investigator(s) in an area of their specific interest and competence. NEI has a programmatic interest in funding grant applications that meet its interests in the area of retinal degenerative diseases.
Get alerted about grants like this
Save a search for “National Eye Institute (NEI), National Institutes of Health (NIH)” or related topics and get emailed when new opportunities appear.
Search similar grants →Key questions and narrative sections extracted from the solicitation.
Specific Aims
Research Strategy
Data Management and Sharing Plan
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Any individual, domestic or foreign, may apply. Eligible organizations include, but are not limited to, higher education institutions, non-profits, small businesses, and government entities. Confirm the full requirements in the official notice before applying.
R01 Research Project Grant (Parent R01 Clinical Trial Not Allowed) is funded by National Eye Institute (NEI), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The solicitation lists 6 required documents: SF424(R&R), Budget forms, PHS 398 Research Plan, Resource Sharing Plan, Data Management Plan, and Senior/Key Person Profile. Check the official notice for formatting and page-limit rules.
Past winners and funding trends for this program
NIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleNIH committed $402 million across 601 multiyear-funded grants in the first eight months of FY 2026 — more than four times the pace of two years ago. The mechanism front-loads obligations into a single fiscal year, leaving less budget for new project starts and squeezing FY 2026 success rates. What researchers and institutions should be doing now.
Read articlePAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.
Read article